Neurosense Therapeutics LTD. 6-K Filing
Ticker: NRSNW · Form: 6-K · Filed: Dec 22, 2025 · CIK: 1875091
Sentiment: neutral
Filing Stats: 257 words · 1 min read · ~1 pages · Grade level 11.2 · Accepted 2025-12-22 11:49:55
Filing Documents
- ea0270556-6k_neuro.htm (6-K) — 11KB
- ea027055601ex99-1_neuro.htm (EX-99.1) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 27KB
- 0001213900-25-124292.txt ( ) — 60KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NeuroSense Therapeutics Ltd. Date: December 22, 2025 By: /s/ Alon Ben-Noon Alon Ben-Noon Chief Executive Officer 3